Free 7-day Trial
All Articles and Columns »

Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm

October 08, 2011 | About:
guruat

guruat

1 followers
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm

Herbalife (HLF): Chairman & CEO Michael Johnson sold 175,205 Shares

Chairman & CEO of Herbalife (HLF) Michael Johnson sold 175,205 shares on 10/03/2011 at an average price of $52.36. Herbalife is a global network marketing company offering a range of science-based weight management products, nutritional supplements and personal care products intended to support weight loss and a healthy lifestyle. Herbalife has a market cap of $6.2 billion; its shares were traded at around $52.37 with a P/E ratio of 18.5 and P/S ratio of 2.3. The dividend yield of Herbalife stocks is 1.5%.

Herbalife reported their 2011 second quarter results. They reported non-GAAP net sales of $879.7 million and non-GAAP net income of $111.2 million.

Chairman & CEO Michael Johnson sold 880,007 shares of HLF stock From June to October. CFO John Desimone sold 22,230 shares of HLF stock on 05/11/2011 at the average price of 53.62. Director Carole Black bought 6,000 shares of HLF stock in May and August. SVP/Managing Dir North America Ibelis Fleming, COO Richard Goudis sold 21,053 shares of HLF stock in September and October.

CNO Financial Group (CNO): Former Director and CEO C James Prieur sold 165,820 Shares

Former Director and CEO of CNO Financial Group (CNO) C James Prieur sold 165,820 shares on 09/30/2011 at an average price of $5.47. CNO Financial Group, Inc. is a holding company for a group of insurance companies operating throughout the United States that develop, market and administer supplemental health insurance, annuity, individual life insurance and other insurance products. Cno Financial Group has a market cap of $1.3 billion; its shares were traded at around $5.23 with a P/E ratio of 7.2 and P/S ratio of 0.3.

Net income was $59.5 million for CNO Financial Group’s 2011 second quarter results.

Former Director and CEO C James Prieur sold 165,820 shares of CNO stock on 09/30/2011 at the average price of 5.47. CEO and CFO Edward J Bonach sold 837 shares of CNO stock on 09/29/2011 at the average price of 5.58. Director Frederick James Sievert, Director John G Turner, Director Roger Keith Long and EVP, Chief Investment Officer Eric R Johnson bought 132,000 shares of CNO stock in August.

Alkermes plc (ALKS): Director and CEO, Alkermes plc Richard F Pops sold 100,000 Shares

Director and CEO, Alkermes plc of Alkermes plc (ALKS) Richard F Pops sold 100,000 shares on 10/03/2011 at an average price of $14.33. Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes Plc has a market cap of $1.42 billion; its shares were traded at around $14.56 with and P/S ratio of 7.6.

Alkermes plc reported their fiscal 2012 financial results. They reported revenues of $61.9 million and GAAP net loss of $13.2 million.

Director and CEO, Alkermes plc Richard F Pops sold 100,000 shares of ALKS stock on 10/03/2011 at the average price of 14.33. SVP, CFO & Treasurer James M Frates sold 200 shares of ALKS stock on 07/08/2011 at the average price of 20. SVP, Corp Dev., Alkermes, Inc. Michael J Landine, Director Robert A Breyer, and SVP, General Counsel Kathryn L Biberstein sold 156,050 shares of ALKS stock in July and October. SVP & COO Gordon G Pugh sold 27,000 shares of ALKS stock in July.

TransDigm (TDG): CEO W Nicholas Howley sold 35,500 Shares

CEO of TransDigm (TDG) W Nicholas Howley sold 35,500 shares on 09/28/2011 at an average price of $84.37. TransDigm Group, through its wholly-owned subsidiaries, including TransDigm Inc. Transdigm has a market cap of $4.15 billion; its shares were traded at around $82.81 with a P/E ratio of 20.7 and P/S ratio of 5. Transdigm had an annual average earnings growth of 18.3% over the past 5 years.

TransDigm reported their quarterly results. They reported net sales of $325.21million and net income of $56.3 million.

CEO W Nicholas Howley sold 205,500 shares of TDG stock in May, August and September. Director Robert J Small bought 214,802 shares of TDG stock in June, August and September.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership

About the author:

guruat
GuruFocus - Stock Picks and Market Insight of Gurus

Rating: 3.2/5 (13 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide